Melanoma Evidence & Self-Care · education / decision-support

← Evidence library

BIB_141

Bishop DT, Demenais F, Goldstein AM et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002;94(12):894–903. GenoMEL international cohort; penetrance ~14% by age 50 / ~24% by age 80 in low-incidence; ~75–91% lifetime in high-incidence (Australia). [Tasks: 14] Tier: 2 Grade: A Retrieved: 2026-05-07

Evidence grade
A
Tier
2
Cited by tasks
14
Identifiers

Full extracted findings & patient-implication analysis: bibliography/BIB_141/findings.md (research corpus). This page is a short context summary — not individualised medical advice.